Cilazaprilat is an angiotensin-converting enzyme (ACE) inhibitor primarily indicated for the treatment of mild-to-moderate hypertension and congestive heart failure. By blocking the conversion of angiotensin… Read more
Cilazaprilat is an angiotensin-converting enzyme (ACE) inhibitor primarily indicated for the treatment of mild-to-moderate hypertension and congestive heart failure. By blocking the conversion of angiotensin I to angiotensin II, this medication promotes vasodilation and reduces aldosterone secretion, effectively lowering blood pressure and enhancing cardiac function. This category offers a comprehensive selection of high-quality reference standards, including stable isotope labelled compounds like Cilazaprilat-d5, alongside associated impurities and metabolites. Pharmaceutical laboratories and analytical research facilities utilize these materials for critical applications such as impurity profiling, method validation, and rigorous quality control testing. Stable isotope labelled standards are particularly valuable as internal standards in mass spectrometry-based assays, ensuring accurate quantification and reliable pharmacokinetic data during drug development and stability studies.